Related Experiment Video
Updated: May 11, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Search for mutations in signaling pathways in head and neck squamous cell carcinoma
Thais Gulim De Carvalho1, Ana Carolina De Carvalho, Danielle Calheiros Campelo Maia
1Cancer Molecular Biology Laboratory, Department of Science Biology, Federal University of São Paulo (UNIFESP), 04039-032, São Paulo, SP, Brazil.
Abstract:
Mutations in JAK-STAT signaling pathway genes have been associated with the development of various hematological tumors, but have not been investigated in head and neck tumors, and the PIK3CA, BRAF and KRAS genes have been described in a few cases of head and neck squamous cell carcinoma (HNSCC). In the present study, we determined the mutation status in members of the MAPK, PI3K-AKT and JAK-STAT pathways in HNSCC. Mutations in the KRAS, BRAF, PIK3CA, JAK1 and JAK2 genes were evaluated in 94 HNSCCs by direct DNA sequencing analysis using cDNA synthesized from RNA extracted from patient tumor cells. All patients evaluated had wild-type KRAS, BRAF and PIK3CA genes. Furthermore, although some known polymorphisms have been found in JAK1 genes (rs45598436, rs17127063, rs2230587, rs3737139, rs2230588 and rs12129819) and JAK2 (rs10429491, rs2230723, rs2230724 and rs41316003), no mutation could be detected. Our data indicate that mutations in these kinase genes seem to be rare events in HNSCC.
Insights
Mutations in key cancer-related genes like KRAS, BRAF, PIK3CA, JAK1, and JAK2 are rare in head and neck squamous cell carcinoma (HNSCC). This study found no mutations in these genes in 94 HNSCC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Mutations in Janus kinase-STAT (JAK-STAT) signaling pathway genes are linked to hematological tumors.
- The PIK3CA, BRAF, and KRAS genes have been identified in a subset of head and neck squamous cell carcinoma (HNSCC) cases.
- The mutation status of MAPK, PI3K-AKT, and JAK-STAT pathways in HNSCC remains largely uninvestigated.
Purpose of the Study:
- To determine the mutation status of genes within the MAPK, PI3K-AKT, and JAK-STAT signaling pathways in HNSCC.
- To investigate the prevalence of mutations in KRAS, BRAF, PIK3CA, JAK1, and JAK2 in HNSCC.
- To assess the potential role of these kinase gene mutations in HNSCC development.
Main Methods:
- Direct DNA sequencing analysis was performed on cDNA synthesized from RNA extracted from 94 HNSCC patient tumor cells.
- Evaluated mutations in KRAS, BRAF, PIK3CA, JAK1, and JAK2 genes.
- Identified known polymorphisms in JAK1 and JAK2 genes.
Main Results:
- All 94 HNSCC patients analyzed presented with wild-type KRAS, BRAF, and PIK3CA genes.
- No mutations were detected in JAK1 or JAK2 genes, although several known polymorphisms were identified.
- The study found no evidence of mutations in the investigated kinase genes within the HNSCC cohort.
Conclusions:
- Mutations in KRAS, BRAF, PIK3CA, JAK1, and JAK2 appear to be infrequent in head and neck squamous cell carcinoma.
- The investigated kinase signaling pathways may not be major drivers of tumorigenesis in the majority of HNSCC cases.
- Further research may be warranted to explore other genetic alterations in HNSCC.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...

